Efficacy and tolerability of pegylated‐interferon alpha‐2a in hemodialysis patients with chronic hepatitis C - Concepedia

Concepedia

Publication | Closed Access

Efficacy and tolerability of pegylated‐interferon alpha‐2a in hemodialysis patients with chronic hepatitis C

94

Citations

21

References

2005

Year

Ömer Faruk Kökoğlu, Hasan Uçmak, Salih Hoşoğlu, Ali Çetinkaya, Bülent Kantarçeken, Mehmet Akif Büyükbeşe, Ismet Onder Isık

Journal of Gastroenterology and Hepatology

Abstract

The present study showed that PEG-IFN alpha-2a for 48 weeks is efficacious and well tolerated in hemodialysis patients with HCV.

References

	Year	Citations

Page 1